Evidence map›Paper›PMID 41047262›Full record

ArticleBMJ open2025

Evaluation of an intervention to increase topical sunscreen use in German outdoor workers: study protocol for the non-randomised controlled intervention study ProtExSun.

Anja Dick, Marc Rocholl, Michaela Ludewig, Christoph Skudlik, Ivone Jakaša, Sanja Kezic, Florentine de Boer, Henk F van der Molen, Swen Malte John

Abstract readClinical Trial Protocol
In one paragraph

Article in BMJ open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Anja DickDepartment of Dermatology, Environmental Medicine and Health Theory, Osnabrück University, Osnabrück, Niedersachsen, Germany andick@uni-osnabrueck.de.ORCID http://orcid.org/0000-0001-5525-9245
Marc RochollDepartment of Dermatology, Environmental Medicine and Health Theory, Osnabrück University, Osnabrück, Niedersachsen, Germany.
Michaela LudewigUniversity of Applied Health Sciences Bochum, Bochum, Nordrhein-Westfalen, Germany.ORCID http://orcid.org/0000-0003-1214-1399
Christoph SkudlikDepartment of Dermatology, Environmental Medicine and Health Theory, Osnabrück University, Osnabrück, Niedersachsen, Germany.
Ivone JakašaLaboratory for Analytical Chemistry, Department of Chemistry and Biochemistry, Faculty of Food Technology and Biotechnology, University of Zagreb, Zagreb, Croatia.
Sanja KezicCoronel Institute of Occupational Health, Amsterdam UMC, Amsterdam Public Health Research Institute, University of Amsterdam, Amsterdam, the Netherlands.
Florentine de BoerCoronel Institute of Occupational Health, Amsterdam UMC, Amsterdam Public Health Research Institute, University of Amsterdam, Amsterdam, the Netherlands.
Henk F van der MolenCoronel Institute of Occupational Health, Amsterdam UMC, Amsterdam Public Health Research Institute, University of Amsterdam, Amsterdam, the Netherlands.ORCID http://orcid.org/0000-0002-0719-2020
Swen Malte JohnDepartment of Dermatology, Environmental Medicine and Health Theory, Osnabrück University, Osnabrück, Niedersachsen, Germany.ORCID http://orcid.org/0000-0001-5406-9458

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionSquamous cell carcinoma and multiple actinic keratoses caused by solar ultraviolet radiation (UVR) are among the most frequently recognised occupational diseases in Germany. Employees who regularly work outdoors, for example, in the construction industry, agriculture, forestry and gardening, are at a higher risk of developing occupational skin cancer. However, sun-safety behaviour in outdoor workers is currently insufficient. Therefore, this study aims to investigate the effectiveness of an intervention to increase sunscreen use among outdoor workers. METHODS AND ANALYSIS: In this non-randomised, controlled intervention study, 234 outdoor workers from different companies in industries with outdoor working activities based in Germany will be included. The study population, aged 18 years and above, has to be intensively exposed to solar UVR of regularly 1 hour or more per day. The intervention group will receive a sunscreen package as well as health education. The control group follows the practice in their companies ('treatment-as-usual'). At the beginning of the study, after 3 months and at the end of the study (after 6 months), both groups filled in different questionnaires. In addition, stratum corneum (SC) samples will be collected at the beginning and after 3 months. The primary outcome-increase in the frequency of sunscreen use during work and in leisure time-will be assessed from data on self-reported sunscreen use. The secondary outcomes include sun protection behaviour, knowledge about sun protection and skin cancer, and acceptance of the provided sunscreens. Further secondary outcomes include internal UV dose and UV-related immune response, determined by the levels of SC biomarkers. Data will be analysed using both descriptive and inferential methods. ETHICS AND DISSEMINATION: The study protocol followed the principles of the Declaration of Helsinki (2013) and was approved by the Ethics Committee of Osnabrück University, Germany (reference Ethik-37/2024). Study results will be disseminated through peer-reviewed publications and conference presentations. TRIAL REGISTRATION NUMBER: DRKS00035178.

Indexed as

Health EducationOccupational DiseasesOccupational ExposureSkin NeoplasmsSunscreening AgentsAdultCarcinoma, Squamous CellFemaleGermanyHumansMaleMiddle AgedNon-Randomized Controlled Trials as TopicSunlightSurveys and QuestionnairesUltraviolet RaysSunscreening Agentsoccupationaloutdoor workerskin cancersun protectionsunscreen

Identifiers

PMID41047262
PMCPMC12506157

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.